Logo image
Synthesis and Evaluation of an 111In-labeled Porphyrin for Lymph Node Imaging
Journal article   Peer reviewed

Synthesis and Evaluation of an 111In-labeled Porphyrin for Lymph Node Imaging

Richard Vaum, Ned D. Heindel, H. Donald Burns, Jacqueline Emrich and Natalie Foster
Journal of pharmaceutical sciences, v 71(11), pp 1223-1226
Nov 1982
PMID: 7175713

Abstract

Biodistribution—111In-labeled porphyrin, synthesis, lymph node imaging, evaluation, rats Imaging, lymph node— 111n-labeled porphyrin, synthesis and evaluation, biodistribution, rats Porphyrin—111In-labeled, synthesis and evaluation, biodistribution, lymph node imaging, rats
111In-labeled tetra(4-N-methylpyridyl) porphyrin was investigated as a possible lymph node imaging agent. A clinically feasible method for the preparation of this radioactive pharmaceutical was developed from experiments with the synthesis and characterization of the unlabeled complex. The in vivo distribution of the compound in Wistar rats was determined as a function of time. Favorable lymph node-blood, lymph node-muscle, and specific lymph node-surrounding tissue ratios were obtained.

Metrics

10 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Chemistry, Medicinal
Chemistry, Multidisciplinary
Pharmacology & Pharmacy
Logo image